Establishment and characterization of human ovarian carcinoma cell lines. 1997

Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
Korean Cell Line Bank, Seoul National University College of Medicine, Seoul, Korea.

Five human ovarian carcinoma cell lines cultured from primary and metastatic tumors of Korean patients were characterized. These lines were isolated from two papillary serous cystadenocarcinomas, two endometrioid carcinomas, and one malignant Brenner tumor. It was shown that the growth of these cell lines was stable when cultured after at least 20 passages. Population doubling times varied from 40 to 67 hr. All lines showed high viability and were proven by DNA fingerprinting analysis to be unique. Contamination by mycoplasma or bacteria was excluded. In two lines, SNU-8 and SNU-840, an elevated level of CA125 antigen secretion could be detected, whereas CEA was undetectable in all five lines. Four different mutations in functional and highly conserved regions of the p53 gene were identified in three of our five lines (60%), namely in SNU-119, SNU-251, and SNU-563. Included were two missense mutations, one in-frame 3-base-pair deletion, and one out-of-frame 1-base-pair deletion. It is interesting to note that one of these three lines, SNU-251, presented an additional simultaneous nonsense mutation of the BRCA1 gene and missense mutation of the hMLH1 gene. In its lacking both wild-type alleles of the BRCA1 gene, SNU-251 might serve as an unusual and important in vitro model for studies related to ovarian carcinoma and the BRCA1 gene. It is thus likely that the establishment and characterization of these permanent human ovarian carcinoma cell lines in continuous cultures can provide useful tools for in vitro studies related to human ovarian carcinomas.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
August 1994, Cancer,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
February 1997, International journal of cancer,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
January 2000, BJU international,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
June 1999, The Laryngoscope,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
June 1999, International journal of cancer,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
June 1979, Gynecologic oncology,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
September 1986, Gynecologic oncology,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
January 1983, Nihon Sanka Fujinka Gakkai zasshi,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
February 1989, Nihon Sanka Fujinka Gakkai zasshi,
Y Yuan, and W H Kim, and H S Han, and J H Lee, and H S Park, and J K Chung, and S B Kang, and J G Park
November 1982, The Journal of urology,
Copied contents to your clipboard!